Chemoproteomics-Based Discovery of CNS-Penetrant Covalent Inhibitors
- Effectively utilizing chemoproteomic platforms to triage hits and facilitate efficient hit-to-lead development
- Conducting high-throughput screening in physiological conditions to streamline translation
- Data to exemplify how chemoproteomics has enabled the detection and optimization of clinically successful therapeutic candidates